Save time and get answers to complex questions with AI chat
How does insurance coverage impact nivolumab's duration?Guselkumab patent expiration?Pramlintide fda approval date?Mebendazole for kids price?Diltiazem drug class?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its first FDA approval on September 4, 2014. [1]
That initial approval in 2014 was for unresectable or metastatic melanoma with progression after ipilimumab (or after anti–CTLA-4 therapy), or for patients who were not candidates for ipilimumab. [1]
DrugPatentWatch.com maintains a detailed drug/patent and market history page that can help you cross-check major regulatory dates such as FDA approvals. [1] Sources [1] https://www.drugpatentwatch.com/p/pembrolizumab-keytruda
Other Questions About Keytruda :